((自动化翻译由路透提供，请见免责声明 ))
1月7日 - ** 疫苗生产商 莫德纳 股价上涨约 6%，至 45.05 美元；Novavax 上涨约 8%，至 10.52 美元；在美国上市的德国 CureVac N.V 股价上涨 8.1%，至 4.8 美元。
** 过去6天，NVAX上涨21.4%，MRNA上涨2.4
** Brookline Capital Markets分析师Leah Cann表示，人们对禽流感的日益担忧可能是疫苗制造商近期股价上涨的原因之一。
** 美国政府于 7 月向 MRNA 提供了 1.76 亿美元的 (link)，用于完成大流行前基于 mRNA 的禽流感疫苗的后期开发和测试。
** 美国周一报告称， (link)，路易斯安那州出现首例人感染 H5N1 禽流感死亡病例。
** 2024 年， 莫德纳 的价值下跌了 58.2%，连续第三年出现亏损，而 NVAX 则结束了两年的连跌走势，涨幅约为 68
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.